Pacira BioSciences
PCRX
PCRX
260 hedge funds and large institutions have $1.21B invested in Pacira BioSciences in 2025 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 87 increasing their positions, 92 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less capital invested
Capital invested by funds: $1.24B → $1.21B (-$21.3M)
5% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 92
Holders
260
Holding in Top 10
2
Calls
$2.5M
Puts
$638K
Top Buyers
| 1 | +$17.8M | |
| 2 | +$7.33M | |
| 3 | +$5.69M | |
| 4 |
Two Sigma Investments
New York
|
+$5.2M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$4.89M |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$11.5M | |
| 3 | -$10.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.15M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.04M |
